The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration
Open accessAbstract
Relating clinical symptoms to neuroanatomical profiles of brain damage and ultimately to tissue pathology is a key challenge in the field of neurodegenerative disease and particularly relevant to the heterogeneous disorders that comprise the frontotemporal lobar degeneration spectrum. Here we present a retrospective analysis of clinical, neuropsychological and neuroimaging (volumetric and voxel-based morphometric) features in a pathologically ascertained cohort of 95 cases of frontotemporal lobar degeneration classified according to contemporary neuropathological criteria. Forty-eight cases (51%) had TDP-43 pathology, 42 (44%) had tau pathology and five (5%) had fused-in-sarcoma pathology. Certain relatively specific clinicopathological associations were identified. Semantic dementia was predominantly associated with TDP-43 type C pathology; frontotemporal dementia and motoneuron disease with TDP-43 type B pathology; young-onset behavioural variant frontotemporal dementia with FUS pathology; and the progressive supranuclear palsy syndrome with progressive supranuclear palsy pathology. Progressive non-fluent aphasia was most commonly associated with tau pathology. However, the most common clinical syndrome (behavioural variant frontotemporal dementia) was pathologically heterogeneous; while pathologically proven Pick's disease and corticobasal degeneration were clinically heterogeneous, and TDP-43 type A pathology was associated with similar clinical features in cases with and without progranulin mutations. Volumetric magnetic resonance imaging, voxel-based morphometry and cluster analyses of the pathological groups here suggested a neuroanatomical framework underpinning this clinical and pathological diversity. Frontotemporal lobar degeneration-associated pathologies segregated based on their cerebral atrophy profiles, according to the following scheme: asymmetric, relatively localized (predominantly temporal lobe) atrophy (TDP-43 type C); relatively symmetric, relatively localized (predominantly temporal lobe) atrophy (microtubule-associated protein tau mutations); strongly asymmetric, distributed atrophy (Pick's disease); relatively symmetric, predominantly extratemporal atrophy (corticobasal degeneration, fused-in-sarcoma pathology). TDP-43 type A pathology was associated with substantial individual variation; however, within this group progranulin mutations were associated with strongly asymmetric, distributed hemispheric atrophy. We interpret the findings in terms of emerging network models of neurodegenerative disease: the neuroanatomical specificity of particular frontotemporal lobar degeneration pathologies may depend on an interaction of disease-specific and network-specific factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Everitt, B. J., Landau, S., & Leese, M. (1974) · Cited by 9,358
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 1×
“Alzheimer-type neurofibrillary tangle pathology was determined using AT8 immunohistochemistry for Braak staging (Braak et al., 2006).”
MethodLitvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350 · cited 9×
“It is increasingly recognized that neurodegenerative diseases target large-scale neural networks that have an intrinsic connectivity laid down in the healthy brain (Seeley et al., 2009).”
BackgroundMethodInfluentialQualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., van Swieten, J. C., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,046
Fiber Tract–based Atlas of Human White Matter Anatomy
Wakana, S., Jiang, H., Nagae-Poetscher, L. M., van Zijl, P. C. M., & Mori, S. (2004) · Radiology · doi:10.1148/radiol.2301021640 · Cited by 1,980
Ventral and dorsal pathways for language
Saur, D., Kreher, B. W., Schnell, S., Kümmerer, D., Kellmeyer, P., Vry, M.-S., Umarova, R., Musso, M., Glauche, V., Abel, S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805234105 · Cited by 1,553
Fiber tract-based atlas of human white matter anatomy
Wakana, S. (2006) · Medical Entomology and Zoology · Cited by 1,531
Cited by
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033118 · Cited by 1,124
Young, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05892-0 · Cited by 596
Self-citationSnowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M. T., Jones, M., Gerhard, A., Davidson, Y. S., Robinson, A., et al. (2012) · Brain · doi:10.1093/brain/awr355 · Cited by 523
Epigenetic mechanisms in neurological disease
Jakovcevski, M., & Akbarian, S. (2012) · Nature Medicine · doi:10.1038/nm.2828 · Cited by 450
Mahoney, C. J., Beck, J., Rohrer, J. D., Lashley, T., Mok, K., Shakespeare, T., Yeatman, T., Warrington, E. K., Schott, J. M., Fox, N. C., et al. (2012) · Brain · doi:10.1093/brain/awr361 · Cited by 438
Self-citationTypical and atypical pathology in primary progressive aphasia variants
Spinelli, E. G., Mandelli, M. L., Miller, Z. A., Santos‐Santos, M. A., Wilson, S. M., Agosta, F., Grinberg, L. T., Huang, E. J., Trojanowski, J. Q., Meyer, M., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24885 · Cited by 409
La Joie, R., Ayakta, N., Seeley, W. W., Borys, E., Boxer, A. L., DeCarli, C., Doré, V., Grinberg, L. T., Huang, E., Hwang, J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.09.001 · Cited by 317
Primary progressive aphasia: a clinical approach
Marshall, C. R., Hardy, C. J. D., Volkmer, A., Russell, L. L., Bond, R. L., Fletcher, P. D., Clark, C. N., Mummery, C. J., Schott, J. M., Rossor, M. N., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8762-6 · Cited by 312
Self-citationClinicopathological correlations in behavioural variant frontotemporal dementia
Perry, D. C., Brown, J. A., Possin, K. L., Datta, S., Trujillo, A., Radke, A., Karydas, A., Kornak, J., Sias, A. C., Rabinovici, G. D., et al. (2017) · Brain · doi:10.1093/brain/awx254 · Cited by 309
Libby, L. A., Ekstrom, A. D., Ragland, J. D., & Ranganath, C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3711-11.2012 · Cited by 303
Warren, J. D., Rohrer, J. D., & Rossor, M. N. (2013) · BMJ · doi:10.1136/bmj.f4827 · Cited by 292
Self-citationMolecular nexopathies: a new paradigm of neurodegenerative disease
Warren, J. D., Rohrer, J. D., Schott, J. M., Fox, N. C., Hardy, J., & Rossor, M. N. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.06.007 · Cited by 265
Self-citationMRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases
Harper, L., Fumagalli, G. G., Barkhof, F., Scheltens, P., O’Brien, J. T., Bouwman, F., Burton, E. J., Rohrer, J. D., Fox, N. C., Ridgway, G. R., et al. (2016) · Brain · doi:10.1093/brain/aww005 · Cited by 264
“As higher AT scores are associated with FTLD pathologies, and in particular TDP43-C pathology associated with semantic dementia (Whitwell et al., 2010; Rohrer et al., 2011), which are less likely to demonstrate atrophy in posterior brain regions, this result is pathologically plausible.”
BackgroundSelf-citationFrontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
Irwin, D. J., Cairns, N. J., Grossman, M., McMillan, C. T., Lee, E. B., Van Deerlin, V. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1380-1 · Cited by 264
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
Bergeron, D., Gorno‐Tempini, M. L., Rabinovici, G. D., Santos‐Santos, M. A., Seeley, W., Miller, B. L., Pijnenburg, Y., Keulen, M. A., Groot, C., van Berckel, B. N. M., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25333 · Cited by 203
Self-citationRedefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
Murley, A. G., Coyle-Gilchrist, I., Rouse, M. A., Jones, P. S., Li, W., Wiggins, J., Lansdall, C., Rodríguez, P. V., Wilcox, A., Tsvetanov, K. A., et al. (2020) · Brain · doi:10.1093/brain/awaa097 · Cited by 162
Frontotemporal Dementia, Where Do We Stand? A Narrative Review
Antonioni, A., Raho, E. M., Lopriore, P., Pace, A. P., Latino, R. R., Assogna, M., Mancuso, M., Gragnaniello, D., Granieri, E., Pugliatti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411732 · Cited by 145
An algorithmic approach to structural imaging in dementia
Harper, L., Barkhof, F., Scheltens, P., Schott, J. M., & Fox, N. C. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306285 · Cited by 137
Self-citationFrontotemporal Lobar Degeneration: Epidemiology, Pathology, Diagnosis and Management
Seltman, R. E., & Matthews, B. R. (2012) · CNS Drugs · doi:10.2165/11640070-000000000-00000 · Cited by 132
Profiles of white matter tract pathology in frontotemporal dementia
Mahoney, C. J., Ridgway, G. R., Malone, I. B., Downey, L. E., Beck, J., Kinnunen, K. M., Schmitz, N., Golden, H. L., Rohrer, J. D., Schott, J. M., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22468 · Cited by 124
Self-citationDevelopment of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122
White matter tract signatures of impaired social cognition in frontotemporal lobar degeneration
Downey, L. E., Mahoney, C. J., Buckley, A. H., Golden, H. L., Henley, S. M., Schmitz, N., Schott, J. M., Simpson, I. J., Ourselin, S., Fox, N. C., et al. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.06.005 · Cited by 94
“Also in line with previous evidence (Whitwell et al., 2010, 2011; Rohrer et al., 2011; Mahoney et al., 2013; McMillan et al., 2013), these data raise the further interesting possibility that DTI signatures may havemolecular specificity: svPPA is closely associated with TDP-43 pathology and produced…”
BackgroundResultInfluentialSelf-citationPhysiological changes in neurodegeneration—mechanistic insights and clinical utility
Ahmed, R. M., Ke, Y. D., Vucic, S., Ittner, L. M., Seeley, W., Hodges, J. R., Piguet, O., Halliday, G., & Kiernan, M. C. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2018.23 · Cited by 91
Toward a glutamate hypothesis of frontotemporal dementia
Benussi, A., Alberici, A., Buratti, E., Ghidoni, R., Gardoni, F., Di Luca, M., Padovani, A., & Borroni, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00304 · Cited by 90
Self-citationIncidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries
Logroscino, G., Piccininni, M., Graff, C., Hardiman, O., Ludolph, A. C., Moreno, F., Otto, M., Remes, A. M., Rowe, J. B., Seelaar, H., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2022.5128 · Cited by 91
Self-citationHarciarek, M., & Cosentino, S. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.763340 · Cited by 77
Peet, B. T., Spina, S., Mundada, N., & La Joie, R. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01101-x · Cited by 74
Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy
Hughes, L. E., Ghosh, B. C. P., & Rowe, J. B. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.009 · Cited by 60
“The similar patterns of network connectivity in bvFTD and PSP might be explained by the partially overlapping profiles of prefrontal cortical atrophy and dysfunction in both diseases, despite diverse patterns of underlying neuropathology (Josephs et al., 2006; Mackenzie et al., 2011; Rohrer et al., 2011; Seelaar et al…”
Biomarkers for diseases with TDP-43 pathology
Steinacker, P., Barschke, P., & Otto, M. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.10.003 · Cited by 57
FTD spectrum: Neuroimaging across the FTD spectrum
Whitwell, J. L. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2019.05.009 · Cited by 53
Agosta, F., Ferraro, P. M., Canu, E., Copetti, M., Galantucci, S., Magnani, G., Marcone, A., Valsasina, P., Sodero, A., Comi, G., et al. (2015) · Radiology · doi:10.1148/radiol.15141869 · Cited by 48
GABAergic cortical network physiology in frontotemporal lobar degeneration
Adams, N. E., Hughes, L. E., Rouse, M. A., Phillips, H. N., Shaw, A. D., Murley, A. G., Cope, T. E., Bevan-Jones, W. R., Passamonti, L., Street, D., et al. (2021) · Brain · doi:10.1093/brain/awab097 · Cited by 47
Neuropathology of frontotemporal lobar degeneration: A review
Bahia, V. S., Takada, L. T., & Deramecourt, V. (2013) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642013dn70100004 · Cited by 48
Functional neuroanatomy of speech signal decoding in primary progressive aphasias
Hardy, C. J. D., Agustus, J. L., Marshall, C. R., Clark, C. N., Russell, L. L., Brotherhood, E. V., Bond, R. L., Fiford, C. M., Ondobaka, S., Thomas, D. L., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.04.026 · Cited by 47
Self-citationSrinivasan, D., Erus, G., Doshi, J., Wolk, D. A., Shou, H., Habes, M., & Davatzikos, C. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117248 · Cited by 45
“At present, an important ody of literature and neuropsychiatry findings are based on Freesurfer egmentations ( Kikinis et al., 2010 ; Rohrer2011 ; Messina et al., 2011 ; abuncu et al., 2011 ).”
BackgroundPatterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration
Taipa, R., Brochado, P., Robinson, A., Reis, I., Costa, P., Mann, D. M., Melo Pires, M., & Sousa, N. (2017) · Neurodegenerative Diseases · doi:10.1159/000457127 · Cited by 37
Hardy, C. J. D., Agustus, J. L., Marshall, C. R., Clark, C. N., Russell, L. L., Bond, R. L., Brotherhood, E. V., Thomas, D. L., Crutch, S. J., Rohrer, J. D., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0278-2 · Cited by 34
Self-citationBalasa, M., Gelpi, E., Martín, I., Antonell, A., Rey, M. J., Grau‐Rivera, O., Molinuevo, J. L., Sánchez‐Valle, R., Lladó, A., & Catalan collaborative Study Group for FTLD (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12194 · Cited by 32
Tovar-Moll, F., de Oliveira-Souza, R., Bramati, I. E., Zahn, R., Cavanagh, A., Tierney, M., Moll, J., & Grafman, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102656 · Cited by 30
Kopach, O., Esteras, N., Wray, S., Rusakov, D. A., & Abramov, A. Y. (2020) · Journal of Cell Science · doi:10.1242/jcs.241687 · Cited by 29
RACF: A Multimodal Deep Learning Framework for Parkinson’s Disease Diagnosis Using SNP and MRI Data
Cao, J., & Long, X. (2025) · Applied Sciences · doi:10.3390/app15084513 · Cited by 22
Metabolomic changes associated with frontotemporal lobar degeneration syndromes
Murley, A. G., Jones, P. S., Coyle Gilchrist, I., Bowns, L., Wiggins, J., Tsvetanov, K. A., & Rowe, J. B. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09824-1 · Cited by 18
Roheger, M., Riemann, S., Brauer, A., McGowan, E., Grittner, U., Flöel, A., & Meinzer, M. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015067.pub2 · Cited by 16
Distinct early symptoms in neuropathologically proven frontotemporal lobar degeneration
Kawakami, I., Arai, T., Shinagawa, S., Niizato, K., Oshima, K., & Ikeda, M. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5387 · Cited by 7
Lower CSF amyloid-beta1–42 predicts a higher mortality rate in frontotemporal dementia
Vieira, D., Durães, J., Baldeiras, I., Santiago, B., Duro, D., Lima, M., Leitão, M. J., Tábuas-Pereira, M., & Santana, I. (2019) · Diagnostics · doi:10.3390/diagnostics9040162 · Cited by 6
“However, patients with FTD may have superimposed amyloid pathology [2].”
BackgroundOhm, D. T., Rhodes, E., Bahena, A., Capp, N., Lowe, M., Sabatini, P., Trotman, W., Olm, C. A., Phillips, J., Prabhakaran, K., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1245886 · Cited by 6
Metadata
- Authors
- Rohrer, J. D., Lashley, T., Schott, J. M., Warren, J. E., Mead, S., Isaacs, A. M., Beck, J., Hardy, J., de Silva, R., Warrington, E., Troakes, C., Al-Sarraj, S., King, A., Borroni, B., Clarkson, M. J., Ourselin, S., Holton, J. L., Fox, N. C., Revesz, T., Rossor, M. N., & Warren, J. D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09-01
- Volume
- 134
- Issue
- 9
- Pages
- 2565-2581
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2151427255
- Cited by
- 359
- References
- 83
- FWCI
- 18.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.